These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 19084843)
21. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Astrup A; Caterson I; Zelissen P; Guy-Grand B; Carruba M; Levy B; Sun X; Fitchet M Obes Res; 2004 Oct; 12(10):1658-69. PubMed ID: 15536230 [TBL] [Abstract][Full Text] [Related]
22. Effects of topiramate on neurophysiological and neuropsychological tests in migraine patients. Kececi H; Atakay S J Clin Neurosci; 2009 Dec; 16(12):1588-91. PubMed ID: 19793661 [TBL] [Abstract][Full Text] [Related]
23. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Bray GA; Hollander P; Klein S; Kushner R; Levy B; Fitchet M; Perry BH Obes Res; 2003 Jun; 11(6):722-33. PubMed ID: 12805393 [TBL] [Abstract][Full Text] [Related]
24. Topiramate in migraine prophylaxis. D'Amico D; Grazzi L; Usai S; Moschiano F; Bussone G Neurol Sci; 2005 May; 26 Suppl 2():s130-3. PubMed ID: 15926010 [TBL] [Abstract][Full Text] [Related]
25. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis. Luo N; Di W; Zhang A; Wang Y; Ding M; Qi W; Zhu Y; Massing MW; Fang Y Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396 [TBL] [Abstract][Full Text] [Related]
26. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. Mei D; Capuano A; Vollono C; Evangelista M; Ferraro D; Tonali P; Di Trapani G Neurol Sci; 2004 Dec; 25(5):245-50. PubMed ID: 15624081 [TBL] [Abstract][Full Text] [Related]
27. Effects of topiramate on migraine frequency and cortical excitability in patients with frequent migraine. Artemenko AR; Kurenkov AL; Filatova EG; Nikitin SS; Kaube H; Katsarava Z Cephalalgia; 2008 Mar; 28(3):203-8. PubMed ID: 18254890 [TBL] [Abstract][Full Text] [Related]
28. Changes in body mass index during long-term topiramate therapy in paediatric epilepsy patients--a retrospective analysis. Reiter E; Feucht M; Hauser E; Freilinger M; Seidl R Seizure; 2004 Oct; 13(7):491-3. PubMed ID: 15324828 [TBL] [Abstract][Full Text] [Related]
29. Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine. Bigal ME; Lipton RB; Biondi DM; Xiang J; Hulihan J Cephalalgia; 2009 Nov; 29(11):1188-96. PubMed ID: 19558539 [TBL] [Abstract][Full Text] [Related]
30. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine. Majkowski J; Neto W; Wapenaar R; Van Oene J Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429 [TBL] [Abstract][Full Text] [Related]
31. Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m(2). Davidson MH; Tonstad S; Oparil S; Schwiers M; Day WW; Bowden CH Am J Cardiol; 2013 Apr; 111(8):1131-8. PubMed ID: 23375187 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J; Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356 [TBL] [Abstract][Full Text] [Related]
33. Topiramate-induced weight loss in schizophrenia: a retrospective case series study. Lévy E; Agbokou C; Ferreri F; Chouinard G; Margolese HC Can J Clin Pharmacol; 2007; 14(2):e234-9. PubMed ID: 17565171 [TBL] [Abstract][Full Text] [Related]
35. Weight gain mitigation with topiramate in mood disorders. Woods TM; Eichner SF; Franks AS Ann Pharmacother; 2004 May; 38(5):887-91. PubMed ID: 15039481 [TBL] [Abstract][Full Text] [Related]
36. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study. Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B; Headache; 2009; 49(10):1454-65. PubMed ID: 19804392 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of add-on topiramate therapy in psychiatric patients with weight gain. Cates ME; Feldman JM; Boggs AA; Woolley TW; Whaley NP Ann Pharmacother; 2008 Apr; 42(4):505-10. PubMed ID: 18364406 [TBL] [Abstract][Full Text] [Related]
38. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129 [TBL] [Abstract][Full Text] [Related]
39. Topiramate for patients with refractory migraine: an observational, multicenter study in Spain. Pascual J; Sánchez del Rio M; Mateos V; Láinez JM; Hernández-Gallego J; Leira R; Jiménez MD Neurologia; 2003 Sep; 18(7):364-7. PubMed ID: 14505244 [TBL] [Abstract][Full Text] [Related]
40. Long-term patterns of weight changes during topiramate therapy: an observational study. El Yaman SH; Mroueh SM; Sinno DD; Mikati MA Neurology; 2007 Jul; 69(3):310-1. PubMed ID: 17636070 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]